Paper
7 September 2023 Current developments, limitations and future directions of CAR T-cell therapy
Daniel Tianlin Yang
Author Affiliations +
Proceedings Volume 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023); 127891R (2023) https://doi.org/10.1117/12.3000298
Event: International Conference on Modern Medicine and Global Health (ICMMGH 2023), 2023, Oxford, United Kingdom
Abstract
Since CAR T-cell therapies were authorized for clinical use in 2017, it has demonstrated massive potential in treating hematological malignancies, with more than 750 active CAR T-cell therapies currently under development around the world. However, despite the successes, many side effects and limitations still remain for this relatively new cancer treatment which is preventing the more extensive usage of this therapy. Thus, more innovative solutions must be established to eliminate or reduce the issues regarding the therapy. This paper will review some of the past and current developments of CAR T-cell therapy, some issues, limitations and its effect on the efficacy of the treatment as well as some of the novel methods and future directions which can be utilized to reduce or eliminate many of the limitations.
(2023) Published by SPIE. Downloading of the abstract is permitted for personal use only.
Daniel Tianlin Yang "Current developments, limitations and future directions of CAR T-cell therapy", Proc. SPIE 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023), 127891R (7 September 2023); https://doi.org/10.1117/12.3000298
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Cancer

Tumors

Oncology

Chromium

Proteins

Clinical trials

Toxicity

Back to Top